ADHD is one of the most common and most misread childhood conditions. Some children get the label too easily, simply for being energetic. Others, particularly girls and quietly inattentive children who daydream through lessons, go years without anyone joining the dots. Both errors have consequences.
Getting the diagnosis right matters because well-targeted support changes outcomes. Children with ADHD who do not get the right help are more likely to struggle academically, lose friendships over impulsive behaviour, and develop secondary anxiety or low self-esteem by the time they reach secondary school. Children who get the right combination of parent training, classroom adjustments, and (where appropriate) medication catch up on most of those gaps.
Healthbooq (healthbooq.com) covers neurodevelopmental conditions in children.
What ADHD Is
ADHD is a neurodevelopmental condition involving persistent difficulty with attention regulation, activity level, and impulse control. The DSM-5 splits it into three presentations:
Predominantly inattentive. Your child can't sustain attention on schoolwork, drifts off during instructions, loses jumpers and water bottles weekly, makes careless errors, and looks like they are not listening even when they are looking at you. This presentation is more common in girls and is the one most often missed because it does not disrupt the classroom.
Predominantly hyperactive-impulsive. Out of their seat constantly, climbing on furniture, talking over the teacher, blurting answers, unable to wait for a turn at four-square. More visible, and usually picked up earlier in primary school.
Combined. Both clusters together. This is the most common presentation seen in clinics.
For a diagnosis, the symptoms must have been present for at least 6 months, be out of step with the child's age, show up in at least two settings (home plus school or nursery), and cause real functional impairment, not just be inconvenient.
The Neuroscience of ADHD
ADHD involves differences in the dopamine and noradrenaline systems that drive the prefrontal cortex. The prefrontal cortex runs working memory, inhibitory control, sustained attention, and planning. Neuroimaging work by Phil Shaw at the NIH (PNAS, 2007) found that cortical maturation in children with ADHD lags behind peers by about 3 years on average. Russell Barkley's executive function model frames ADHD as a self-regulation problem rather than a willpower one.
The practical implication: a 10-year-old with ADHD often handles frustration, transitions, and waiting more like a 6 or 7-year-old. Parenting and teaching strategies pitched to a younger child's emotional maturity tend to work better than those pitched to chronological age.
Assessment and Diagnosis
In the UK, assessment goes through CAMHS or community paediatrics; older teenagers may be seen by adolescent or adult psychiatry with a transition pathway. A proper assessment includes a structured interview with parents and child, standardised rating scales (Conners or SDQ) completed by parents and teachers, school reports, and a careful look at conditions that mimic or accompany ADHD.
There is no blood test, brain scan, or screen-based test that diagnoses ADHD on its own. The diagnosis is clinical. Co-occurring conditions are the rule rather than the exception: roughly 50% of children with ADHD also meet criteria for an anxiety disorder, around 30% for depression by adolescence, and a substantial proportion have dyslexia, dyspraxia (DCD), autism, or sleep problems.
Treatment
Under 5s. Parent training in ADHD-specific behaviour management is first-line per NICE NG87. Medication is not routinely recommended at this age.
Age 5 to 17 with moderate-to-severe ADHD.
Parent training. Structured programmes like the New Forest Parenting Programme (designed specifically for ADHD), Incredible Years, and Stepping Stones Triple P teach ADHD-informed strategies: shorter instructions, immediate feedback, scaffolded routines, and ways to handle dysregulation without escalating it. The evidence base is solid.
Medication. Methylphenidate (Ritalin, Concerta, Equasym) is the first-line stimulant; it boosts dopamine and noradrenaline availability in the prefrontal cortex and helps roughly 70% of children who try it. Lisdexamfetamine (Elvanse) is the second-line stimulant. Atomoxetine, a non-stimulant noradrenaline reuptake inhibitor, is used when stimulants cause unacceptable side effects, when there is co-occurring tic disorder, or when anxiety is prominent. Stimulants suppress appetite, so monitoring height and weight every 6 months is standard.
School-based strategies. Seating near the teacher and away from windows or chatty peers, written instructions to back up verbal ones, chunked tasks with interim deadlines, visual timetables, and movement breaks every 20-30 minutes all help. The expectation should not drop, but the path to meeting it should be scaffolded.
ADHD UK (adhduk.co.uk) and ADDISS (addiss.co.uk) run helplines and family resources.
Key Takeaways
ADHD affects roughly 5-7% of school-age children (AAP and NICE estimates). It is defined by persistent inattention, hyperactivity, and impulsivity that go beyond what is developmentally typical and that show up in at least two settings, usually home and school. DSM-5 recognises three presentations: inattentive, hyperactive-impulsive, and combined. NICE guideline NG87 recommends parent training as first-line for under-5s and reserves medication for moderate-to-severe cases in school-age children. Methylphenidate is the most commonly prescribed first-line stimulant, effective in around 70% of children who try it. ADHD often travels with dyslexia, DCD, autism, anxiety, and sleep problems, so a thorough assessment looks for all of these.
